CA 15-3 and CA 27.29

Keywords: Cancer Antigen, Breast Cancer

Upon completion of this activity, you will be able to:

• discuss the use of CA 15-3 and CA 27.29 levels in monitoring patients undergoing treatment for breast cancer and for the detection of recurrent and metastatic disease.
• compare the composition of immunoassays for the measurement of CA 15-3 and CA 27.29.
• list sample handling and storage requirements for specimens to be analyzed for CA 15-3 and/or CA 27.29.

The ASCP designates this educational activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation n the activities.

ASCP designates this activity for a maximum of 1 CMLE credits. This activity meets CMP and state licensure requirements for laboratory personnel.